Low-Molecular Weight Inhibitors Targeting the Alternative Co
2026-06-16
This review analyzes advances in the development of low-molecular weight inhibitors, particularly those selective for complement factor B and D, for targeted regulation of the alternative complement pathway. The findings highlight the therapeutic promise of highly selective, orally available agents such as Iptacopan (LNP023) for a range of complement-mediated diseases.
Baicalein: Applied Workflows for Cancer and Inflammation Res
2026-06-16
Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) empowers researchers to precisely dissect apoptosis and inflammation pathways via potent 12-LOX inhibition. This guide translates advanced protocols, troubleshooting insights, and comparative advantages into actionable workflows for maximizing experimental rigor in cancer research.
Trelagliptin succinate (SKU A3889): Data-Driven Answers for
2026-06-15
This article addresses common laboratory challenges in diabetes mellitus research by providing scenario-driven guidance on using Trelagliptin succinate (SKU A3889). Drawing on published protocols and quantitative studies, we explore how this selective DPP-4 inhibitor enhances assay reliability, reproducibility, and data interpretation for cell viability and metabolic signaling studies.
FH1 Small Molecule: Advancing iPS Hepatocyte Differentiation
2026-06-15
FH1, a small molecule supplied as Catalog No. B3700, directly enhances the function and maturity of iPS cell-derived hepatocytes in vitro. Its application leads to higher albumin secretion, increased CYP3A4 expression, and reduced alpha-fetoprotein, supporting reliable hepatocyte-like cell culture for research. These properties make FH1 a benchmark tool for cultured hepatocyte function enhancement.
Anagliptin-Induced Vasorelaxation: Roles of Kv Channels and
2026-06-14
This article reviews recent findings on Anagliptin's direct vasorelaxant action in rabbit aorta, highlighting its reliance on Kv channel activation and SERCA pump function, independent of classical endothelial or cyclic nucleotide pathways. These results clarify novel mechanisms by which DPP-4 inhibitors may influence vascular tone in diabetes and cardiovascular research.
Nutlin-3a in Cancer Research: Precision MDM2 Inhibition and
2026-06-13
Explore how Nutlin-3a, a leading MDM2 inhibitor, enables precision p53 pathway activation and apoptosis induction in cancer research. This article delivers unique protocol guidance and integrates advanced insights from recent glioblastoma studies.
Nebivolol Hydrochloride: Advanced Workflows for β1 Blockade
2026-06-12
Nebivolol hydrochloride empowers cardiovascular scientists with high selectivity and purity for dissecting β1-adrenergic signaling. This guide translates bench protocols and troubleshooting into actionable steps for reproducible, high-impact assays.
Rifampin in Mechanistic Transcriptional Modulation Research
2026-06-12
Explore the unique role of rifampin as a rifamycin antibiotic in advanced transcriptional regulation studies. This article delves deeper into mechanistic applications, comparative workflows, and practical assay optimization, setting it apart from standard guides.
Bradykinin B2 Antagonism in Human Synovial Fibroblasts: New
2026-06-11
This study characterizes the pharmacology of the non-peptide B2 receptor antagonist MEN16132 versus icatibant in human synovial fibroblasts. The findings elucidate novel pro-inflammatory signaling roles for bradykinin and confirm the potent anti-inflammatory effects of B2 antagonism, with implications for osteoarthritis research and translational inflammation models.
JNK-IN-7: Selective JNK Inhibitor for Targeted Apoptosis Ass
2026-06-11
JNK-IN-7’s unparalleled selectivity empowers researchers to dissect JNK-dependent apoptosis and inflammatory signaling with unprecedented precision. This guide translates recent mechanistic insights into actionable workflows, troubleshooting strategies, and advanced applications, making it essential reading for anyone pursuing MAPK signaling pathway research or innate immune modulation.
Lanabecestat (AZD3293) in Alzheimer's Disease Research Workf
2026-06-10
Lanabecestat (AZD3293) empowers Alzheimer's disease researchers to precisely modulate amyloid-beta production using a potent, blood-brain barrier-permeable BACE1 inhibitor. This guide translates breakthrough findings into practical protocols, troubleshooting strategies, and advanced applications for maximizing the impact of Lanabecestat in neurodegenerative disease models.
Structural Insights into TRPM3 Modulation by Primidone and N
2026-06-10
This study uses cryo-EM to reveal the molecular mechanisms by which neurosteroids and the anticonvulsant Primidone regulate the TRPM3 ion channel. Findings clarify how disease mutations, agonists, and inhibitors alter TRPM3 gating, providing a structural foundation for therapeutic targeting in pain and neurodevelopmental disorders.
PF-04971729 (Ertugliflozin): Applied Workflows in Diabetes R
2026-06-09
Ertugliflozin (PF-04971729) stands out as a benchmark SGLT2 inhibitor in diabetes and renal research, enabling rigorous modeling of glucose reabsorption and cardiometabolic endpoints. This guide details experimental workflows, troubleshooting strategies, and unique translational insights to maximize reproducibility and impact with APExBIO’s reagent.
Tiamulin Inhibits TNF-α and Alleviates Psoriasis-Like Dermat
2026-06-09
A recent high-throughput screening study identified Tiamulin fumarate as a potent small-molecule inhibitor of TNF-α signaling, capable of reducing inflammation in psoriasis-like dermatitis models. This work highlights Tiamulin's translational potential beyond veterinary use, particularly in targeting NF-κB and MAPK pathways implicated in skin inflammation.
Anagliptin (SK-0403): Advanced Workflows for Vascular Resear
2026-06-08
Anagliptin (SK-0403) empowers researchers to dissect DPP-4 inhibition and novel vasorelaxant mechanisms, bridging diabetes and cardiovascular research. This guide delivers actionable workflows, troubleshooting strategies, and highlights translational insights from the latest reference study.
460 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page